CBAI
$0.01
Cord Blood America
$.00
2.63%
CBAI
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Monday
Nov 25
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when CBAI reports earnings?
Beat
Meet
Miss

Where is CBAI's stock price going from here?
Up
Flat
Down
Stock chart of CBAI
Analysts
Summary of analysts' recommendations for CBAI
Score
Grade
Pivots
Resistance
$0.01
$0.01
$0.01

$0.01

Support
$0.01
$0.01
$0.01
Tweet
Growth
Description
Cord Blood America, headquartered in Santa Monica, California, is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. In addition, it engages in the collection, transportation, testing, and preservation of umbilical cord blood.